Latest Share Purchase Plan News

NOVONIX has hit a critical milestone by delivering a synthetic graphite anode sample to Panasonic, supporting a planned production start in late 2027. The company secured A$21.66 million in fresh capital to fund production readiness, while navigating an evolving US trade and policy landscape aimed at boosting domestic battery materials.

Comet Ridge has completed a $40.9 million capital raise combining a Share Purchase Plan and a two-tranche placement to fund full acquisition and development of its Mahalo Gas Project.

Saturn Metals has locked in $100 million from a two-tranche placement, anchored by major shareholders including Golden Crane, to push its Apollo Hill Gold Project towards production. A $5 million Share Purchase Plan will offer further participation to existing investors.

Santana Minerals made significant strides in the June quarter at its Bendigo-Ophir Gold Project, progressing regulatory approvals, expanding mineralisation, and securing robust funding to underpin development plans.

Vitrafy Life Sciences reported a breakthrough 94.4% post-thaw platelet recovery in US Army Phase II testing, secured major US blood network partnerships, and raised $32 million to accelerate US expansion and device manufacturing.

Microba Life Sciences has wrapped up a $5.41 million capital raise combining a $5 million institutional Placement and a $407,500 Share Purchase Plan, strengthening its balance sheet to accelerate growth in Australia and the UK.

Beetaloo Energy has pushed construction of its Carpentaria Gas Plant forward, maintaining schedule and budget for Q4 2026 commissioning, while its Carpentaria-5H well delivers steady gas flow with low decline rates.

ImpediMed reported a 3% revenue increase to $3.6 million in Q4 FY26, bolstered by a $15.3 million capital raise and strategic leadership hires as it pushes growth in cancer survivorship, heart health, and weight management.

Strategic Energy Resources (ASX:SER) is gearing up for a major 2026 field season with three high-impact diamond drilling programs across its Queensland copper-gold projects, backed by joint ventures and government grants. A $1.5 million capital raise recently completed will support drilling activities, while a new $6 million JV with Sumitomo Metals Mining targets the Bulimba Gold Project.

Syntara secured positive FDA feedback for its Phase 2b amsulostat trial in myelofibrosis and raised $8 million to extend its cash runway to Q3 2027, while preliminary data showed promising brain inflammation reduction in a Parkinson’s-related disorder.

Acrow Limited has raised $16 million through an oversubscribed Share Purchase Plan, exceeding its $10 million underwriting target. The additional funds will be directed towards debt reduction, reinforcing the company’s financial position ahead of a pending placement approval.

Ardea Resources pushes back the completion of its Kalgoorlie Nickel Project DFS to pursue optimisation opportunities, while securing strong multi-level government backing and maintaining a robust financial position.